avatar_investigadors.jpg

Angel Vila Rovira

QiSP-Tar

ORCID: 0000-0002-9543-8907

USR Reus-Tarragona

Direcció SAP Tarragona-Valls

Fisioterapia

Biografia

Projectes

Incidencia y caracterización de perfiles de bajo/alto riesgo de complicación en personas >60 años con COVID19.

  • IP: Olga Ochoa Gondar, Angel Vila Corcoles
  • Durada: 2020-2022
  • Finiançadors: Instituto de Salud Carlos III

Estudio de cohortes de base poblacional, con seguimiento retrospectivo-prospectivo de 4 meses (01/03/2020-30/06/2020), que incluirá 48.000 personas >60 años de Tarragona (1.500 de ellas institucionalizadas). Objetivos: (i) conocer la incidencia real de infección por COVID-19, discriminando según casos «confirmados» (PCR+) y/o «sospechosos»(COVID19-like sin confirmación PCR); (ii) identificar la frecuencia de presentación (inicial y durante la evolución) de síntomas y signos de la enfermedad en ambos tipos de pacientes (confirmados/sospechosos); (iii) caracterizar el perfil de presentación clínica (síntomas y signos) de la infección por COVID-19 en la población y explorar modelos de predicción de perfiles de bajo/alto riesgo de complicación (empeoramiento brusco, necesidad de hospitalización/UCI, muerte) en función de posibles covariables predictoras (sexo, edad, síntomas/signos, comorbilidad y medicación previa).

Publicacions

Patient Safety Incidents in Primary Care: Comparing APEAS-2007 (Spanish Patient Safety Adverse Events Study in Primary Care) with Data from a Health Area in Catalonia (Spain) in 2019

M. GENS-BARBERÀ, M. ASTIER-PEÑA, N. HERNÁNDEZ-VIDAL, I. HOSPITAL-GUARDIOLA, F. BEJARANO-ROMERO, E. OYA-GIRONA, Y. MENGÍBAR-GARCIA, N. MANSERGAS-COLLADO, A. VILA-ROVIRA, S. MARTÍNEZ-TORRES, C. REY-REÑONES and F. MARTÍN-LUJÁN
Healthcare. 2024 Jun 1; . doi:10.3390/healthcare12111086; PMID:38891161

Incidence and risk factors of pneumococcal pneumonia in adults: a population-based study

O. OCHOA-GONDAR, V. TORRAS-VIVES, C. DE DIEGO-CABANES, E. SATUÉ-GRACIA, A. VILA-ROVIRA, M. FORCADELL-PERISA, D. RIBAS-SEGUÍ, C. RODRÍGUEZ-CASADO and A. VILA-CÓRCOLES
BMC Pulmonary Medicine. 2023 Jun 8; . doi:10.1186/s12890-023-02497-2; PMID:37291502

Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017-2018

A. VILA-CORCOLES, O. OCHOA-GONDAR, C. DE DIEGO-CABANES, E. SATUE-GRACIA, V. TORRAS-VIVES, M. FORCADELL-PERIS, D. RIBAS-SEGUI, A. VILA-ROVIRA and C. RODRIGUEZ-CASADO
Vaccine: X. 2023 Apr 1; . doi:10.1016/j.jvacx.2023.100264; PMID:36798107

Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination among adults with immunocompromising conditions

E. SATUE-GRACIA, C. CABANES, A. VILA-ROVIRA, C. RODRIGUEZ-CASADO, O. OCHOA-GONDAR and A. VILA-CORCOLES
EUROPEAN RESPIRATORY JOURNAL. 2022 Sep 4; . doi:10.1183/13993003.congress-2022.263;

Evaluating pneumococcal vaccine’s effectiveness against pneumonia among adults over 50 years in Catalonia, 2017-2018

C. CABANES, A. VILA-CORCOLES, E. SATUE-GRACIA, O. OCHOA-GONDAR, A. VILA-ROVIRA and M. FORCADELL-PERIS
EUROPEAN RESPIRATORY JOURNAL. 2022 Sep 4; . doi:10.1183/13993003.congress-2022.258;

Lugar de atención, sintomatología y curso clínico, gravedad y letalidad en 536 casos confirmados de COVID-19 en adultos mayores de 50 años en el área de Tarragona, marzo-junio de 2020.

Vila-Córcoles Á, Vila-Rovira Á, Satué-Gracia EM, Ochoa-Gondar O, de Diego-Cabanes C, Hospital-Guardiola I, Forcadell-Peris MJ, Martín-Luján F and Basora-Gallisà J
Revista Espanola de Salud Publica. 2021 Sep 8; PMID:34493700

  • Any: 08/09/2021
  • FI: 1.333
  • Article

ABSTRACT Treatment setting, symptomatology, clinical course, severity degree and case-fatality rate in 536 adults over 50 years with laboratory-confirmed COVID-19 in Tarragona, Spain, March-June 2020

A. VILA-CORCOLES, A. VILA-ROVIRA, E. SATUE-GRACIA, O. OCHOA-GONDAR, C. DE DIEGO-CABANES, I. HOSPITAL-GUARDIOLA, M. FORCADELL-PERIS, F. MARTIN-LUJAN and J. BASORA-GALLISA
Revista Espanola de Salud Publica. 2021 Sep 8;

  • Any: 08/09/2021
  • FI: 1.333
  • Article

COVID19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection: a population-based cohort study in Southern Catalonia, Spain, March-June 2020

A. VILA-CORCOLES, E. SATUE-GRACIA, A. VILA-ROVIRA, C. DE DIEGO-CABANES, M. FORCADELL-PERIS, I. HOSPITAL-GUARDIOLA, O. OCHOA-GONDAR and J. BASORA-GALLISA
BMC PUBLIC HEALTH. 2021 Oct 6; . doi:10.1186/s12889-021-11879-2; PMID:34615512

  • Any: 06/10/2021
  • FI: 4.135
  • Article

Development of a predictive prognostic rule for early assessment of COVID-19 patients in primary care settings

A. VILA-CORCOLES, E. SATUE-GRACIA, A. VILA-ROVIRA, C. DE DIEGO-CABANES, M. FORCADELL-PERIS and O. OCHOA-GONDAR
Atencion Primaria. 2021 Nov 1; . doi:10.1016/j.aprim.2021.102118; PMID:34139400

  • Any: 01/11/2021
  • FI: 2.206
  • Article

Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: a population-based cohort study in Southern Catalonia, Spain

A. VILA-CORCOLES, E. SATUE-GRACIA, O. OCHOA-GONDAR, C. TORRENTE-FRAGA, F. GOMEZ-BERTOMEU, A. VILA-ROVIRA, I. HOSPITAL-GUARDIOLA, C. DE DIEGO-CABANES, F. BEJARANO-ROMERO, D. ROVIRA-VECIANA and J. BASORA-GALLISA
Journal of Clinical Hypertension. 2020 Aug 1; . doi:10.1111/jch.13948; PMID:32710674

  • Any: 01/08/2020
  • FI: 3.738
  • Article

Incidence and Risk of Pneumococcal Pneumonia in Adults with Distinct Underlying Medical Conditions: A Population-Based Study

A. VILA-CORCOLES, O. OCHOA-GONDAR, A. VILA-ROVIRA, M. ARAGON, L. ESTEBAN-JULVEZ, N. CHAMORRO, I. HOSPITAL, E. SATUE, J. BLADE, C. DE DIEGO, F. GOMEZ-BERTOMEU and X. RAGA
LUNG. 2020 Jun 1; . doi:10.1007/s00408-020-00349-y; PMID:32253492

  • Any: 01/06/2020
  • FI: 2.584
  • Article

Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain

A. VILA-CORCOLES, O. OCHOA-GONDAR, E. SATUE-GRACIA, C. TORRENTE-FRAGA, F. GOMEZ-BERTOMEU, A. VILA-ROVIRA, I. HOSPITAL-GUARDIOLA, C. DE DIEGO-CABANES, F. BEJARANO-ROMERO and J. BASORA-GALLISA
BMJ Open. 2020 Jan 1; . doi:10.1136/bmjopen-2020-041577; PMID:33303459

  • Any: 01/01/2020
  • FI: 2.692
  • Article

Antipneumococcal vaccination in Catalonian adults: Vaccine coverages and adequacy to distinct guideline recommendations

O. OCHOA-GONDAR, A. VILA-CORCOLES, C. DE DIEGO, E. SATUE, A. VILA-ROVIRA and M. ARAGON
Atencion Primaria. 2018 Nov 1; . doi:10.1016/j.aprim.2017.05.015; PMID:29373143

  • Any: 01/11/2018
  • FI: 1.346
  • Article

Incidence and lethality of ischaemic stroke among people 60 years or older in the region of Tarragona (Spain), 2008-2011

A. VILA-CORCOLES, E. SATUE-GRACIA, O. OCHOA-GONDAR, C. DE DIEGO-CABANES, A. VILA-ROVIRA, J. BLADE, F. BOBE, R. CASANOVA, M. JARIOD and R. REIG
REVISTA DE NEUROLOGIA. 2014 Dec 1; . doi:10.33588/rn.5911.2014264; PMID:25418143

Evaluating Clinical Effectiveness of Pneumococcal Vaccination in Preventing Stroke: The CAPAMIS Study, 3-Year Follow-up

A. VILA-CORCOLES, O. OCHOA-GONDAR, T. RODRIGUEZ-BLANCO, C. DE DIEGO-CABANES, E. SATUE-GRACIA, A. VILA-ROVIRA and C. FRAGA
Journal of Stroke & Cerebrovascular Diseases. 2014 Jul 1; . doi:10.1016/j.jstrokecerebrovasdis.2013.12.047; PMID:24656243

  • Any: 01/07/2014
  • FI: 1.669
  • Article

Incidence of pneumococcal infections among children under 15 years in southern Catalonia throughout the heptavalent conjugate vaccine era, 2002-2009

A. VILA-CORCOLES, O. OCHOA-GONDAR, A. GUZMAN-AVALOS, F. GOMEZ-BERTOMEU, E. FIGUEROLA-MASSANA, X. RAGA-LURIA, C. DE DIEGO-CABANES, A. GUTIERREZ-PEREZ, A. VILA-ROVIRA and M. RODRIGUEZ-FERNANDEZ
INFECTION. 2013 Apr 1; . doi:10.1007/s15010-012-0345-3; PMID:23055151

  • Any: 01/04/2013
  • FI: 2.864
  • Article

Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in patients with chronic pulmonary diseases: a matched case-control study.

Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Gutierrez-Perez A and Vila-Rovira A
Human Vaccines & Immunotherapeutics. 2012 May 1; . doi:10.4161/hv.19466; PMID:22634442

Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain.

Satué-Gracia EM, Vila-Córcoles A, de Diego-Cabanes C, Vila-Rovira A, Torrente-Fraga C, Gómez-Bertomeu F, Hospital-Guardiola I, Ochoa-Gondar O and Martín-Luján F
Medicina Clinica (english Ed.). 2022 Apr 23; . doi:10.1016/j.medcle.2021.03.034; PMID:35492428

Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain

E. SATUE-GRACIA, A. VILA-COORCOLES, C. DE DIEGO-CABANES, A. VILA-ROVIRA, C. TORRENTE-FRAGA, F. GOMEZ-BERTOMEU, I. HOSPITAL-GUARDIOLA, O. OCHOA-GONDAR and F. MARTIN-LUJAN
MEDICINA CLINICA. 2022 Mar 18; . doi:10.1016/j.medcli.2021.03.027; PMID:34074472

Evaluation of incidence and risk profile for suffering Covid-19 infection by underlying conditions among middle-aged and older adults in Tarragona

A. VILA-CORCOLES, O. OCHOA-GONDAR, C. TORRENTE-FRAGA, A. VILA-ROVIRA, E. SATUE-GRACIA, I. HOSPITAL-GUARDIOLA, C. DE DICGO-CABANES, F. GOMEZ-BERTOMEU and J. BASORA-GALLISA
Revista Espanola de Salud Publica. 2020 Jun 26; PMID:32588837

  • Any: 26/06/2020
  • FI: 0.756
  • Article

Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016

A. VILA-CORCOLES, I. HOSPITAL, O. OCHOA-GONDAR, E. SATUE, C. DE DIEGO, A. VILA-ROVIRA, F. GOMEZ-BERTOMEU, X. RAGA and M. ARAGON
Vaccine. 2020 Jan 29; . doi:10.1016/j.vaccine.2019.11.012; PMID:31759735

  • Any: 29/01/2020
  • FI: 3.641
  • Article

Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017

A. VILA-CORCOLES, O. OCHOA-GONDAR, C. DE DIEGO, E. SATUE, A. VILA-ROVIRA and M. ARAGON
Eurosurveillance. 2019 Jul 18; . doi:10.2807/1560-7917.ES.2019.24.29.1800446; PMID:31339099

  • Any: 18/07/2019
  • FI: 6.454
  • Article

Incidencia poblacional de neumonía neumocócica hospitalizada en adultos con distintos niveles de riesgo en cataluña durante 2015, estudio EPIVAC.

Vila Córcoles Á, Hospital Guardiola I, Ochoa Gondar O, Vila Rovira Á, Aragón Pérez M and Satué Gracia E
Revista Espanola de Salud Publica. 2019 Apr 30; PMID:31313756

  • Any: 30/04/2019
  • FI: 0.746
  • Article

Population-based incidence of hospitalised pneumococcal pneumonia in adults with distinct baseline risk strata in Catalonia throughout 2015, the EPIVAC study

A. CORCOLES, O. GONDAR, A. ROVIRA, M. PEREZ and E. GRACIA
Revista Espanola de Salud Publica. 2019 Apr 30;

  • Any: 30/04/2019
  • FI: 0.746
  • Article

Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study

A. VILA-CORCOLES, O. OCHOA-GONDAR, C. DE DIEGO, E. SATUE, M. ARAGON, A. VILA-ROVIRA, F. GOMEZ-BERTOMEU, R. MAGAROLAS, E. FIGUEROLA-MASSANA, X. RAGA, M. PEREZ and F. BALLESTER
BMC INFECTIOUS DISEASES. 2018 Apr 27; . doi:10.1186/s12879-018-3096-7; PMID:29699550

  • Any: 27/04/2018
  • FI: 2.565
  • Article

Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up

A. VILA-CORCOLES, O. OCHOA-GONDAR, T. RODRIGUEZ-BLANCO, A. GUTIERREZ-PEREZ, A. VILA-ROVIRA, F. GOMEZ, X. RAGA, C. DE DIEGO, E. SATUE and E. SALSENCH
BMC PUBLIC HEALTH. 2012 Mar 22; . doi:10.1186/1471-2458-12-222; PMID:22436146

  • Any: 22/03/2012
  • FI: 2.076
  • Article

Patronat

Col·laboradors

Acreditacions